Skip to main content
. 2015 May 13;107(8):djv137. doi: 10.1093/jnci/djv137

Figure 2.

Figure 2.

The expression level of FGL2 protein in glioma cell lines and tumor lysate from glioblastoma patients. A) FGL2 protein levels were detected by western blot in fibroblast cells (MRC5 and WI38), glioblastoma cancer cell lines (LN18, U87, and U251), or glioblastoma cancer stem cells (gCSC13, gCSC811, and gCSC929). B) Expression level of FGL2 protein in tumor lysate of glioblastoma (grade: IV) patients and low-grade glioma (grade: I~III) patients. FGL2 was measured in tumor tissue lysate from glioblastoma patients (n = 13) and low-grade glioma patients (n = 7) using an enzyme-linked immunosorbent assay (ELISA) kit. Data were presented as the mean ± SD. An unpaired t test was used to calculate the two-sided P values.